Discover trends, market shifts, and competitive outlooks for the synthetic hormones industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Synthetic Hormones Market In 2029?

The market size for synthetic hormones has experienced robust growth in the past few years. The projection is that it will expand from $6.38 billion in 2024 to $6.77 billion in 2025, registering a compound annual growth rate (CAGR) of 6.2%. This growth during the historic period is caused by factors such as animal growth promotion, performance enhancement, environmental impact, fertility treatments, and management of menopausal symptoms.

Predictions indicate a consistent expansion in the synthetic hormones market in the upcoming years. It is anticipated to reach $8.15 billion by 2029, with a compound annual growth rate (CAGR) of 4.7%. Factors fueling this growth during the forecast period include advancements in transgender healthcare, increased healthcare spending and insurance coverage, regulatory approvals, and broader applications of synthetic hormones. Key trends during this forecast period involve the emergence of plant-based hormone therapy, the incorporation of hormone therapy into anti-aging treatments, technological progress in drug delivery, and a shift towards hormone-free birth control.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14515&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Synthetic Hormones Market?

The upswing in cases of hormonal irregularities is projected to spur the expansion of the synthetic hormones market in the future. Hormonal imbalances, implying an excess or deficiency of a hormone in the bloodstream, can be a result of stress, aging, health issues, or lifestyle factors, interrupting typical hormone production and control within the body. Synthetic hormones are employed to enhance or substitute natural hormones during these imbalances, facilitating the management of bodily functions and mitigating symptoms related to shortages or surpluses. For example, data from the NHS Business Services Authority, a non-departmental body based in the UK, reveals that in 2022, approximately 7.80 million hormone replacement therapy (HRT) items were dispensed in England, signifying a surge of 35.0% compared to the prior year. Hence, the escalating occurrence of hormonal imbalances is promoting the development of the synthetic hormones market.

Which Primary Segments of the Synthetic Hormones Market Are Driving Growth and Industry Transformations?

The synthetic hormones market covered in this report is segmented –

1) By Product Type: Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types

2) By Route of Administration: Oral, Nasal, Topical, Intravenous

3) By Application: Growth Hormone Deficiency, Thyroid Hormone Deficiency, Menopause, Male Hypogonadism, Other Applications

4) By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Hormones: Corticosteroids, Estrogens and Progesterone, Androgens, Progestins

2) By Peptide Hormones: Insulin, Growth Hormones, Thyroid Stimulating Hormones, Leptin

3) By Amino Acid Derivatives: Thyroxine (T4), Epinephrine (Adrenaline), Melatonin, Serotonin

4) By Other Product Types: Vitamin D Derivatives, Prostaglandins, Gonadotropins

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=14515&type=smp

Which Regions Are Key Players in the Growth of the Synthetic Hormones Market?

North America was the largest region in the synthetic hormones market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Synthetic Hormones Market?

Leading corporations in the synthetic hormone sector are concentrating their efforts on creating cutting-edge offerings such as recombinant human growth hormone to boost their market earnings. Recombinant human growth hormone is a man-made hormone used in treating growth hormone deficiency in both children and adults, as well as some specific ailments related to the deficiency of growth hormone. For example, in February 2022, Pfizer Inc., a pharmaceutical corporation based in the US, and OPKO Health Inc., a US-established medical test and medication firm, garnered marketing consent for NGENLA (somatrogon) injections, to be used once-minute every week in the European Union. These injections aim to address pediatric growth hormone deficiency in children and adolescents aged three years and above. This innovative long-acting injection offers an alternative solution for those suffering from growth issues due to lack of adequate growth hormone secretion. Unlike daily growth hormone injections, NGENLA is given subcutaneously and remains in the body for a longer duration, enabling a once-a-week application.

View the full report here:

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

What Parameters Are Used to Define the Synthetic Hormones Market?

Synthetic hormones are artificially produced substances that mimic the function of natural hormones in the body. These hormones are typically created through chemical synthesis rather than being derived from natural sources and are used in medical treatments to regulate various physiological processes or to replace hormones that the body may not produce in sufficient quantities.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14515

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model